Ali Riza Caliskan
Overview
Explore the profile of Ali Riza Caliskan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caliskan A, Erdogan M
Hepatol Forum
. 2024 Oct;
5(4):204-206.
PMID: 39355832
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, potentially life-threatening, drug-induced hypersensitivity reaction that involves hematological abnormalities (atypical lymphocytosis, eosinophilia), lymphadenopathy, skin eruption, and internal organ...
2.
Atas N, Caliskan A, Akatli A
Mod Rheumatol Case Rep
. 2024 Aug;
9(1):214-217.
PMID: 39185604
Polymyalgia rheumatic (PMR) associated amyloidosis is an extremely rare condition that can be rapidly progressive with high morbidity and mortality and management is challenging. Tocilizumab is a monoclonal anti-IL-6 receptor...
3.
Ataman E, Harputluoglu M, Bilgic Y, Cagin Y, Erdogan M, Kutlu R, et al.
Medeni Med J
. 2024 Mar;
39(1):33-38.
PMID: 38511832
Objective: Our aim was to present the results of endoscopic retrograde cholangiopancreatography (ERCP) after living donor liver transplantation (LDLT) between February 2015 and June 2021. Methods: Clinical data included LDLT...
4.
Caliskan A, Muhip Harputluoglu M, Samdanci E, Cirik S, Yilmaz S
Hepatol Forum
. 2023 May;
4(2):74-77.
PMID: 37250929
Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the...
5.
Marasco G, Cremon C, Barbaro M, Cacciari G, Falangone F, Kagramanova A, et al.
Gut
. 2023 Jan;
PMID: 36591612
Objectives: The long-term consequences of COVID-19 infection on the gastrointestinal tract remain unclear. Here, we aimed to evaluate the prevalence of gastrointestinal symptoms and post-COVID-19 disorders of gut-brain interaction after...
6.
Efe C, Tascilar K, Gerussi A, Bolis F, Lammert C, Ebik B, et al.
J Autoimmun
. 2022 Sep;
132:102906.
PMID: 36088883
Background: Data regarding outcome of Coronavirus disease 2019 (COVID-19) in vaccinated patients with autoimmune hepatitis (AIH) are lacking. We evaluated the outcome of COVID-19 in AIH patients who received at...
7.
Harputluoglu M, Caliskan A, Akbulut S
World J Transplant
. 2022 Apr;
12(3):59-64.
PMID: 35433333
Autoimmune hepatitis is a chronic inflammatory disease of the liver that is characterized by circulating autoantibodies and elevated serum globulin levels. Liver transplantation may be required for patients with acute...
8.
Montano-Loza A, Ronca V, Ebadi M, Hansen B, Hirschfield G, Elwir S, et al.
J Hepatol
. 2022 Feb;
77(1):84-97.
PMID: 35143897
Background & Aims: Autoimmune hepatitis can recur after liver transplantation (LT), though the impact of recurrence on patient and graft survival has not been well characterized. We evaluated a large,...
9.
Caliskan A, Gul M, Yilmaz I, Otlu B, Uremis N, Uremis M, et al.
Hum Exp Toxicol
. 2021 Nov;
40(12_suppl):S693-S701.
PMID: 34791921
Background And Aim: The epithelial cells are the strongest determinants of the physical intestinal barrier. Tight junctions (TJs) hold the epithelial cells together and allow for selective paracellular permeability. Larazotide...
10.
Marasco G, Cremon C, Barbaro M, Salvi D, Cacciari G, Kagramanova A, et al.
Am J Gastroenterol
. 2021 Nov;
117(1):147-157.
PMID: 34751672
Introduction: Gastrointestinal (GI) symptoms in coronavirus-19 disease (COVID-19) have been reported with great variability and without standardization. In hospitalized patients, we aimed to evaluate the prevalence of GI symptoms, factors...